Shree Ram Proteins Reports ₹15.25 Crore Q2 FY27 Net Loss

Shree Ram Proteins Limited reported a standalone net loss of ₹15.25 crore for the quarter ended September 30, 2026, while revenue from operations declined 8.5% year-on-year to ₹15.06 crore. The Q2 FY27 result also showed an operating loss before exceptional items of ₹4.06 crore, compared with ₹0.26 crore a year earlier.

What did Shree Ram Proteins report for Q2 FY27?

Shree Ram Proteins reported revenue from operations of ₹15.06 crore in Q2 FY27, against ₹16.46 crore in the corresponding quarter of FY26. The decline of ₹1.40 crore represents an 8.5% year-on-year reduction in revenue for the September quarter.

The company recorded a loss after tax of ₹15.25 crore, substantially higher than the ₹4.97 crore loss reported in the year-ago quarter. The results were disclosed in the company's standalone results statement published on November 7, 2026, for the quarter and half year ended September 30, 2026.

The operating loss before exceptional items was ₹4.06 crore in the latest quarter, compared with ₹0.26 crore in Q2 FY26. This indicates that the loss at the operating level widened even before exceptional items were considered.

The supplied results information does not include an earnings-call transcript or management guidance for the quarter. The reported figures therefore reflect the financial-results statement rather than management commentary on future operations or performance targets.

Which Q2 FY27 financial figures are most important?

The most important Q2 FY27 figures are ₹15.06 crore of revenue from operations, a ₹4.06 crore operating loss before exceptional items, and a ₹15.25 crore loss after tax. These measures show a lower revenue base alongside significantly larger losses than in the comparable quarter a year earlier.

The results statement also reported a loss per share of ₹0.70 for Q2 FY27. Investors should distinguish the operating loss before exceptional items from the final loss after tax, as the latter captures additional items recorded during the period.

A ₹1.18 crore inventory write-off was included in the quarter's loss. The disclosed comparison refers to the prior year's half-year period, when inventory write-offs totalled ₹6.14 crore, rather than providing a like-for-like Q2 FY26 inventory-write-off figure.

Why did the quarterly loss widen?

The disclosed results show that Shree Ram Proteins' quarterly loss widened alongside lower revenue and a larger operating loss before exceptional items. The company also recorded the ₹1.18 crore inventory write-off during Q2 FY27, which contributed to the loss reported for the period.

The available material does not provide a detailed management explanation for the movement in revenue, operating costs, finance costs, or other expenses. It would therefore not be appropriate to attribute the larger loss to any specific business condition beyond the reported operating loss and inventory write-off.

The company reports one standalone business segment, Solvent Products. That makes the quarterly outcome directly relevant to the operating performance of its reported segment, without separate segment-level revenue or profit disclosures in the supplied information.

How does Q2 FY27 compare with Shree Ram Proteins' recent performance?

Q2 FY27 follows a period of continued losses for Shree Ram Proteins. The supplied historical data states that FY25 EBITDA was negative ₹16.94 crore and the loss after tax was ₹21.08 crore, while FY26 loss after tax narrowed to ₹10.11 crore.

The FY26 loss included a ₹6.14 crore inventory write-off, according to the available information. That means the narrower FY26 loss should be read alongside the effect of this inventory-related charge, rather than as evidence of a confirmed operating recovery.

For Q1 FY27, the supplied quarterly data showed revenue from operations of nil, total income of ₹1.40 crore, and a loss after tax of ₹6.36 crore. The Q2 results statement subsequently reported ₹15.06 crore of revenue from operations, but the company has not provided an earnings-call transcript in the supplied material to explain the change between the two quarters.

What does the result mean for investors and the business?

For investors, the reported Q2 FY27 figures highlight two immediate points: revenue was lower than the year-ago quarter, and losses widened materially at both the operating and net-profit levels. The loss after tax of ₹15.25 crore was close to the level of quarterly revenue, underlining the financial pressure indicated by the results statement.

No share-price movement, trading-volume response, or market reaction data has been provided with the results. As a result, the impact on SRPL's market valuation cannot be quantified from the available material. The company is listed on NSE under the symbol SRPL.

The company has also disclosed approval to raise funds through a rights issue of up to 220 million shares. The provided material does not state the issue price, record date, final terms, or use of proceeds. Those details will be relevant for assessing the potential capital impact and any dilution for existing shareholders.

Conclusion

Shree Ram Proteins' Q2 FY27 standalone results showed revenue of ₹15.06 crore, down 8.5% from a year earlier, while the loss after tax widened to ₹15.25 crore. A larger operating loss before exceptional items and a ₹1.18 crore inventory write-off were the key disclosed factors within the quarter's reported financial outcome.

Investors should watch for further exchange disclosures on the proposed rights issue of up to 220 million shares, including its terms and intended use of funds. Future financial filings will also be important for tracking revenue consistency, operating losses, inventory-related charges, and any management commentary that accompanies subsequent results.